Aadi Bioscience, Inc.
AADINASDAQHealthcare
$2.05
$-0.05(-2.38%)
Market Cap$94891630
P/E Ratio—
52W High$3.812
52W Low$1.21
Aadi Bioscience, Inc. (AADI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AADI · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 12, 2026EPS Actual
-$0.04
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 12, 2026
After Market Close
AADI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 12, 2026 | — | -$0.04 | — | — | — | — |
| — Q4 FY2025 | Nov 4, 2025 | — | -$0.26 | — | — | — | — |
| — Q3 FY2025 | Aug 5, 2025 | — | -$0.76 | — | — | — | — |
| — Q2 FY2025 | May 6, 2025 | — | $1.83 | — | $0.01B | — | — |
| ▼ Q1 FY2025 | Mar 18, 2025 | -$0.30 | -$0.67 | -123.3% | $0.01B | $0.01B | -2.6% |
| — Q4 FY2024 | Nov 6, 2024 | -$0.46 | -$0.46 | +0.0% | $0.01B | $0.01B | -2.1% |
| ▲ Q3 FY2024 | Aug 7, 2024 | -$0.71 | -$0.54 | +23.9% | $0.01B | $0.01B | -0.3% |
| ▼ Q2 FY2024 | May 8, 2024 | -$0.66 | -$0.68 | -3.0% | $0.01B | $0.01B | -17.0% |
Q1 FY2026
Mar 12, 2026
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 4, 2025
EPS Actual
-$0.26
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 5, 2025
EPS Actual
-$0.76
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 6, 2025
EPS Actual
$1.83
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 18, 2025Miss
EPS Actual
-$0.67
EPS Est.
-$0.30
EPS Surpr.
-123.3%
Revenue
$0.01B
Q4 FY2024
Nov 6, 2024
EPS Actual
-$0.46
EPS Est.
-$0.46
EPS Surpr.
+0.0%
Revenue
$0.01B
Q3 FY2024
Aug 7, 2024Beat
EPS Actual
-$0.54
EPS Est.
-$0.71
EPS Surpr.
+23.9%
Revenue
$0.01B
Q2 FY2024
May 8, 2024Miss
EPS Actual
-$0.68
EPS Est.
-$0.66
EPS Surpr.
-3.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q3 FY2025 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q2 FY2025 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q1 FY2025 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q4 FY2024 | $-0.39 | $-0.29 | $-0.19 | 1 |
| Q3 FY2024 | $-0.60 | $-0.46 | $-0.29 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 12, 2026 | — | $1.71 | — | — |
| — Q4 FY2025 | Nov 4, 2025 | — | $1.71 | — | — |
| — Q3 FY2025 | Aug 5, 2025 | — | $1.71 | — | — |
| — Q2 FY2025 | May 6, 2025 | — | $1.71 | — | — |
| ▼ Q1 FY2025 | Mar 18, 2025 | -123.3% | $2.10 | $2.05 | -2.38% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +0.0% | $1.99 | $2.12 | +6.53% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +23.9% | $1.40 | $1.35 | -3.57% |
| ▼ Q2 FY2024 | May 8, 2024 | -3.0% | $2.11 | $1.84 | -12.80% |
Q1 FY2026—
Report Date
Mar 12, 2026
EPS Beat/Miss
—
Price Before
$1.71
Price After
—
Q4 FY2025—
Report Date
Nov 4, 2025
EPS Beat/Miss
—
Price Before
$1.71
Price After
—
Q3 FY2025—
Report Date
Aug 5, 2025
EPS Beat/Miss
—
Price Before
$1.71
Price After
—
Q2 FY2025—
Report Date
May 6, 2025
EPS Beat/Miss
—
Price Before
$1.71
Price After
—
Q1 FY2025-2.38%
Report Date
Mar 18, 2025
EPS Beat/Miss
-123.3%
Price Before
$2.10
Price After
$2.05
Q4 FY2024+6.53%
Report Date
Nov 6, 2024
EPS Beat/Miss
+0.0%
Price Before
$1.99
Price After
$2.12
Q3 FY2024-3.57%
Report Date
Aug 7, 2024
EPS Beat/Miss
+23.9%
Price Before
$1.40
Price After
$1.35
Q2 FY2024-12.80%
Report Date
May 8, 2024
EPS Beat/Miss
-3.0%
Price Before
$2.11
Price After
$1.84
Avg Beat Reaction+1.48%
Avg Miss Reaction-7.59%
Beat Rate2 / 8 quarters
Largest Move-12.80% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AADI ends December
Aadi Bioscience, Inc. (AADI) most recently reported earnings on March 12, 2026 for Q1 FY2026, posting EPS of $-0.04 (in line with the analyst consensus of —). The next AADI earnings date is expected around September 1, 2026.
Each quarter, investors track AADI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AADI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AADI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AADI earnings · 4 questionsAadi Bioscience, Inc.'s next earnings report is expected around September 1, 2026. AADI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AADI historically reports after market close (AMC).
AADI earnings datewhen is AADI earningsAADI next earnings datewhen does AADI report earningsAADI earnings calendar
▸ Source: FMP · Aadi Bioscience, Inc. SEC filings · US GAAP · Aadi Bioscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026